Uptake of new hepatitis C treatment.

The Kirby Institute has release the first report on the number of people initiating treatment for hepatitis C, using the new generation medicines.  The new generation medicines became available on the Pharmaceutical Benefits Scheme (PBS) from 1 March this year. The report shows that an estimated 1,811 people commenced using the new medicines during March. The report is available for download by using the button below.

National Hepatitis Health Promotion Award Winners

Hepatitis Australia would like to congratulate the winners of the National Hepatitis Health Promotion Awards were announce on Thursday evening 19th May. 

Left to Right: Dr Ben Cowie, Pam Woods and Maria Scarlett (Liverzone)

Left to Right: Dr Ben Cowie, Pam Woods and Maria Scarlett (Liverzone)

Innovation in Viral Hepatitis Health Promotion.
Awarded to 'Liverzone' by the Northern Territory AIDS and Hepatitis Council

Awarded for the planning, implementation and evaluation of a project that has successfully adopted a new and innovative approach to health promotion, and has contributed significantly to the health and wellbeing of people affected by viral hepatitis.

Volunteering Excellence Award – Viral Hepatitis Health Promotion.
Awarded to Pam Woods

Awarded to a voluntary worker to recognise and honour their commitment and contributions as a volunteer to improving the health and wellbeing of people affected by viral hepatitis.

Outstanding Service Award – Viral Hepatitis Health Promotion.
Awarded to Dr Ben Cowie and Susan Curruthers
Presented to individuals who have displayed outstanding service to the viral hepatitis sector in the area of health promotion over a significant period of time and, whose dedication and diligence has contributed significantly to the health and wellbeing of people affected by viral hepatitis.

New medicines for hepatitis C now available.

A new generation of direct-acting antiviral medications are now available to Australians living with chronic hepatitis C. They are more effective, easier to take and have fewer side-effects than the older medications. The Australian Government has listed these new medicines on the Pharmaceutical Benefits Scheme (PBS), ensuring they are accessible and affordable to all people with hepatitis C.  This is a leap forward in the management and treatment of hepatitis C and positions Australia as a world leader in publicly-funded access to these new, highly effective medicines.

Support us.

You can also donate directly to Hepatitis Australia. Please contribute to our aim of a world without viral hepatitis by making a tax deductible donation. Find out more

Hepatitis Australia is a non-government, not-for-profit organisation that became incorporated in 1997. We do not provide services to individuals. To locate hepatitis services in your area visit the services page or call the Info line on 1300 437 222. Our members consist of the state and territory hepatitis organisations and other key services providing hepatitis services.

Latest News

Page updated: 23 May 2016